2-Methoxyethyl-18-methoxycoronaridinate
id:
2-methoxyethyl-18-methoxycoronaridinate-299-12606322
title:
2-Methoxyethyl-18-methoxycoronaridinate
text:
(−)-2-Methoxyethyl-18-methoxycoronaridinate (ME-18-MC) is a second generation synthetic derivative of ibogaine developed by the research team led by the pharmacologist Stanley D. Glick from the Albany Medical College and the chemist Martin E. Kuehne from the University of Vermont. In animal studies it has shown similar efficacy to the related compound 18-methoxycoronaridine (18-MC) at reducing self-administration of morphine and methamphetamine but with higher potency by weight, showing anti-add
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/2-Methoxyethyl-18-methoxycoronaridinate
date created:
date modified:
2024-01-22T01:04:32Z
main entity:
{"identifier":"Q4596899","url":"https://www.wikidata.org/entity/Q4596899"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/8c/2-Methoxyethyl-18-methoxycoronaridinate.svg","width":136,"height":74}
fields total:
13
integrity:
15